- Fund-raising should enable strategic delivery
CollPlant has announced the signing of a definitive agreement with a US investor for a $5m private placing. The investment is in three tranches: signing the agreement; approval; and successful up-listing to the NASDAQ exchange. This is a significant step for CollPlant, in our opinion, as it enables the company to develop strategically by increasing its distribution of Vergenix products and progress its earlier-stage rhCollagen technology bioInk for 3D printing of organs and tissues. We have increased our rNPV to $73m (NIS262m) as a result of rolling our model forward a quarter and using the Q2 cash and first tranche of the fund-raising.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.